NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for vitiligo in major trial
Disease control OngoingThis study tests a daily pill called povorcitinib to see if it can safely bring back skin color in people with nonsegmental vitiligo, a condition where white patches appear on the skin. About 450 adults will receive either the drug or a placebo for 52 weeks. The main goal is to m…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a daily pill help restore skin color in vitiligo?
Disease control OngoingThis phase 3 trial tests an oral drug called povorcitinib in about 467 adults with nonsegmental vitiligo, a condition causing white patches on the skin. Participants take the drug or a placebo daily for 52 weeks to see if it safely improves skin color on the face and body. The go…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC